#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Eosinophilic granulomatosis with polyangiitis Cutaneous lupus erythematosus Noonan syndrome Vulval cancer Leukocyte adhesion deficiency type I Glomerulonephritis membranous Glycogen storage disease type I Uterine leiomyosarcoma Haemophilia A without inhibitors Renal disorder Lung adenocarcinoma Breast cancer metastatic Anti-myelin-associated glycoprotein associated polyneuropathy Immunodeficiency Vitamin B12 deficiency More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Diagnostics Advanced systemic mastocytosis – Diagnostics Stevens-Johnson syndrome Methylmalonic acidaemia – Life with Disease Metachromatic leukodystrophy – Basic Information Glycogen storage disease type I – Basic Information Alagille syndrome – Diagnostics Hepatoblastoma – Trials in Disease Von Willebrand’s disease – Trials in Disease Waldenstrom’s macroglobulinaemia – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Retinol Palmitate Incb000928 VERTEPORFIN Etuvetidigene Autotemcel Vancomycin Hydrochloride Relacorilant Bevacizumab GSK3862995B L-Arginine Hydrochloride Ima402 Abc-15A-116 Foscarnet Azathioprine Dextrose Bp Mbs2320 Ale.c04 Minocycline Tezacaftor Camlipixant Potassium Oxybate More therapies…

    Learn about Your Condition

    Lichen planus Bacteraemia Klinefelter's syndrome Blood disorder Malignant melanoma of eyelid Aplasia pure red cell Bone marrow failure Latent tuberculosis Haemorrhage intracranial Infantile apnoea HER2 positive gastric cancer Colitis Gastrointestinal melanoma Chondrosarcoma Thrombosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Oesophageal cancer metastatic

  • Study of Trastuzumab Deruxtecan and Drug Combination for Patients with Advanced or Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Capecitabine
    • Cisplatin
    • Fluorouracil
    Austria Belgium Czechia France Germany Italy +6
  • Study of HLX22, Trastuzumab, and Chemotherapy for Patients with Advanced or Metastatic Stomach and Gastroesophageal Cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Gastric cancer
    • Metastatic gastric cancer
    • Oesophageal cancer metastatic
    Investigated Drugs:
    • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2
    • Pembrolizumab
    Germany Greece Italy Poland Portugal Romania +1
  • Study of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Gastric cancer
    • Oesophageal cancer metastatic
    • Oesophageal carcinoma
    Investigated Drugs:
    • Domvanalimab
    • Zimberelimab
    • Calcium Folinate
    France Greece Hungary Italy Lithuania Poland +3

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.


European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!